In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
February 22nd, 2022
3K views
We describe here, the establishment and application of an Tg(Myh6-cre)1Jmk/J /Gt(ROSA)26Sortm38(CAG-GCaMP3)Hze/J (referred to as αMHC-Cre/Rosa26A-Flox-Stop-Flox-GCaMP3 below) mouse reporter line for cardiac reprogramming assessment. Neonatal cardiac fibroblasts (NCFs) isolated from the mouse strain are converted into induced cardiomyocytes (iCMs), allowing for convenient and efficient evaluation of reprogramming efficiency and functional maturation of iCMs via calcium (Ca2+) flux.
Overview
This article presents a novel mouse reporter line, αMHC-Cre/Rosa26A-Flox-Stop-Flox-GCaMP3, for assessing cardiac reprogramming. The established protocol allows for the evaluation of induced cardiomyocytes (iCMs) derived from neonatal cardiac fibroblasts (NCFs) through calcium flux analysis.
Key Study Components
Area of Science
- Cardiac reprogramming
- Induced cardiomyocytes
- Calcium flux analysis
Background
- The αMHC-Cre/Rosa26A-Flox-Stop-Flox-GCaMP3 mouse model facilitates cardiac research.
- Neonatal cardiac fibroblasts can be efficiently converted into iCMs.
- Calcium flux serves as a key indicator of iCM functional maturation.
- This method enhances reproducibility in cardiac reprogramming studies.
Purpose of Study
- To establish a reliable platform for assessing iCM functional maturation.
- To simplify evaluation procedures in cardiac reprogramming research.
- To provide insights into cardiomyocyte differentiation and cardiac function.
Methods Used
- Isolation of neonatal cardiac fibroblasts from P0 to P2 pups.
- Conversion of NCFs into induced cardiomyocytes.
- Assessment of functional maturation via calcium flux measurement.
- Evaluation of reprogramming efficiency and cardiac function.
Main Results
- Successful conversion of NCFs into functional iCMs.
- Calcium flux exclusively observed in iCMs indicates maturation.
- Enhanced reproducibility of results in cardiac reprogramming studies.
- Protocol applicable for evaluating cardiomyocyte differentiation.
Conclusions
- The αMHC-Cre/Rosa26A-Flox-Stop-Flox-GCaMP3 mouse model is a valuable tool.
- Calcium flux analysis is effective for assessing iCM maturation.
- This method can advance research in cardiac reprogramming and function.
Frequently Asked Questions
What is the significance of calcium flux in iCMs?
Calcium flux is a key indicator of functional maturation in induced cardiomyocytes.
How are neonatal cardiac fibroblasts isolated?
NCFs are isolated from P0 to P2 pups to obtain the necessary cells for reprogramming.
What advantages does this mouse model provide?
It simplifies evaluation procedures and enhances the reproducibility of cardiac reprogramming studies.
Can this protocol be used for other types of cardiac research?
Yes, it can also be applied to evaluate cardiomyocyte differentiation and cardiac function.
What are induced cardiomyocytes?
Induced cardiomyocytes are fibroblasts that have been reprogrammed to exhibit cardiomyocyte characteristics.
How does this study contribute to cardiac reprogramming?
It provides a new method to evaluate iCMs' functional maturation, advancing the field of cardiac reprogramming.
Executive Industry Relevance
Assessing functional maturation of induced cardiomyocytes remains a critical bottleneck in cardiac reprogramming for regenerative therapies. This protocol provides a direct, reporter-based readout of calcium flux that enables objective evaluation of iCM functional maturity, supporting target validation and mechanistic de-risking in early discovery. By linking transcriptional reprogramming to functional electrophysiological output, it improves predictive confidence in preclinical models and informs portfolio decisions on cardiac repair strategies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypothesis by linking transcription factor delivery (MGT) to functional calcium transient readouts in reprogrammed cells.
- Operational Value: Uses GCaMP3 fluorescence to isolate successfully reprogrammed iCMs, reducing reliance on indirect markers like gene expression.
- Predictive Value: Calcium flux serves as a functional biomarker that supports biological de-risking and target confidence in cardiac reprogramming approaches.
Screening & Assay Development
- Assay Readiness: Establishes a standardized, fluorescence-based platform for quantifying calcium flux as a quantitative dependent variable in iCM maturation assays.
- Reproducibility: The reporter mouse line ensures consistent detection of functional iCMs across experiments, supporting assay standardization.
- Scalability: Compatible with fluorescence microscopy and adaptable to higher-throughput imaging systems for screening reprogramming efficiency.
Translational & Preclinical Research
- Disease Relevance: Provides a disease-relevant system to assess iCM functional maturation in vitro, bridging discovery to preclinical validation.
- Translational Continuity: Enables longitudinal assessment of iCM maturation from early reprogramming stages to functional electrophysiological competence.
- Mechanistic De-risking: Calcium flux measurements help distinguish structurally reprogrammed cells from functionally mature iCMs, reducing false-positive outcomes.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target validation through lead identification to preclinical evaluation, specifically enabling functional assessment after transcriptional reprogramming but before in vivo validation.
- Discovery Biology: Supports hypothesis testing by determining whether reprogramming factors induce not only marker expression but also functional calcium handling.
- Screening: Delivers assay-ready, reproducible biological systems with quantitative calcium flux readouts for compound or condition comparison.
- Analytics: Generates fluorescence-based temporal data on calcium oscillation frequency and amplitude, enabling statistical comparison of reprogramming conditions.
- Translational Research: Connects in vitro reprogramming outcomes to functional cardiomyocyte phenotypes relevant to preclinical models.
- Enterprise Reuse: Establishes a reusable reporter platform applicable across multiple cardiac reprogramming targets and differentiation protocols.
Operational & Enterprise Impact
- Scientific Value: Provides direct measurement of functional maturation, reducing mechanistic ambiguity in reprogramming outcomes.
- Operational Value: Enhances standardization and reproducibility through genetic reporter specificity, minimizing variability from antibody-based methods.
- Strategic Value: Improves go/no-go decisions by linking molecular reprogramming to functional electrophysiological readiness.
- Portfolio Impact: Enables risk-adjusted prioritization of reprogramming strategies based on functional iCM yield and maturation quality.
Implementation Considerations
- Requires expertise in mouse breeding, cardiac tissue isolation, and fluorescence microscopy.
- Depends on access to the αMHC-Cre/Rosa26A-Flox-Stop-Flox-GCaMP3 mouse line and viral delivery systems for MGT.
- Necessitates standardized culture conditions and timing for consistent iCM induction and calcium flux assessment.
- Adaptation to alternative fibroblast sources or species may require validation of reporter specificity and calcium signaling fidelity.
- Practical limitations include dependence on spontaneous contraction for flux visualization and potential variability in transfection efficiency.
Biopharma FAQs
Why does calcium flux measurement matter for target validation in cardiac reprogramming?
Calcium flux serves as a functional readout that distinguishes induced cardiomyocytes with mature electrophysiological properties from those expressing only structural markers, directly supporting target validation by linking transcriptional reprogramming to functional output.
How does isolation of neonatal cardiac fibroblasts fit into the discovery pipeline for reprogramming studies?
Isolating neonatal cardiac fibroblasts provides a reproducible, disease-relevant starting cell population for reprogramming, enabling consistent input material for target validation and assay development in early discovery.
What do quantitative calcium flux measurements enable in assessing iCM maturation?
Quantitative calcium flux measurements enable objective comparison of reprogramming efficiency and functional maturation across conditions, providing a dependent variable for statistical analysis and hit selection in screening campaigns.
Why are replication requirements important for calcium flux assays in cross-functional collaboration?
Replication ensures assay reliability and reproducibility across teams and sites, which is essential for translating reprogramming findings into preclinical decisions and maintaining data integrity in multi-stakeholder projects.
What statistical analysis capabilities are required before implementing calcium flux assessment in iCM studies?
Implementation requires the ability to quantify fluorescence intensity changes over time, compare oscillation frequency and amplitude between groups, and apply appropriate statistical tests to determine significant differences in functional maturation.
Chapters in this video
0:04
Introduction
0:53
Isolation and Selection of Neonatal Myh6-Cre/Rosa26A-Flox-Stop-Flox-GCaMP3 Mice Hearts
1:23
Isolation of Neonatal Cardiac Fibroblasts (NCFs)
2:43
Reprogramming NCFs to iCMs with MGT Encoding Retrovirus Infection
3:28
Results: In Vitro Assessment of Cardiac Reprogramming
4:20
Conclusion
